NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/24/2024
Back to search
Official data from USPTO
BIOSIEVE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
09/24/2024
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
03/22/2023
Registration date
09/24/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/24/2024
Last transaction
09/24/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
08/29/2023
First use in commerce
08/29/2023
Drawing code
3
Owner type
99
Owner location
Hangzhou Zhejiang, CN
Examiner
TATE-NAGHI, JACQUELINE
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
VivaChek Biotech (Hangzhou) Co., Ltd.
Representatives
Elias Hantula
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Cardiovascular treatment preparations; Chemical preparations for pharmaceutical or medical purposesfor treating cancercardiovascular diseasescardiovascular injuriesischemic tissue damageconditions for which immunosuppression is therapeutic; Diagnostic biomarker reagents for medical purposes; Diagnostic preparations for veterinary purposes; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Pharmaceutical preparations for treating diabetes; Reagents for use in veterinary genetic testing; Test strips for measuring blood glucose levels; Diagnostic preparations for medical purposes; Reagent paper for medical purposes; Veterinary diagnostic reagents
Publications
History of USPTO decisions and trademark events.
17 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/24/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/21/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/21/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/06/2024
IUAF
USE AMENDMENT FILED
07/06/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/06/2024
EISU
TEAS STATEMENT OF USE RECEIVED
05/28/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/19/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/23/2024
PUBO
PUBLISHED FOR OPPOSITION
01/23/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/03/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/21/2023
DOCK
ASSIGNED TO EXAMINER
12/16/2023
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/14/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/13/2023
NWAP
NEW APPLICATION ENTERED
03/25/2023
Continuous trademark protection
Get notified about every new filing that threatens BIOSIEVE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.